Journal Guide

Critical Reviews in Clinical Laboratory Sciences publishes review articles in all areas of clinical laboratory science (including clinical biochemistry, clinical hematology, clinical microbiology, pathology, transfusion medicine, genetics, and immunology). Our aim is to meet the needs of, and build a bridge between, two constituencies: to allow clinical scientists to broaden their primary knowledge base to include the vocabulary, concepts, and information from the various fields of medicine that they require to perform their work; and to allow laboratory physicians to keep pace with the rapid developments taking place in scientific disciplines that directly impact their daily activities. The editorial staff strive to ensure the inclusion of sufficient introductory background material in each article to allow a non-specialist reader to understand the text that follows.Reviews are generally solicited from international experts on the advice of members of the Editorial Advisory Board. However, other authors are encouraged to submit outlines of proposed reviews to the Editor-in-Chief for consideration, following which a formal invitation may be issued. Primary authors are encouraged to recruit collaborators to help in forging a representative consensus and comprehensive coverage of the selected topic. The adjective “Critical” implies a balanced synthesis of results and conclusions that are frequently contradictory and controversial. A single expert, whose name appears under the names of the authors, is assigned the task of refereeing the paper. This open process promotes a fairer review than may be the case when the identity of the referee is concealed by the mask of anonymity. The emphasis upon “Sciences” generally disqualifies topics of a professional nature (such as instrumentation, quality assurance, and methodology) unless they are based upon novel scientific concepts.The scope of the journal includes the clinical laboratory aspects of:*Diagnosis, monitoring, prognosis, and management of disease*Detection and prevention of disease among apparently healthy persons *Biochemistry of disease *Genetics of disease*Immunobiology of disease *Markers of disease *CancerRead More: http://informahealthcare.com/page/lab/Description.

Current Chemical Biology aims to publish full-length and mini reviews as well as research papers on exciting new developments at the chemistry-biology interface, covering topics relating to Chemical Synthesis, Science at Chemistry-Biology Interface and Chemical Mechanisms of Biological Systems.

Current Drug Metabolism aims to cover all the latest and outstanding developments in drug metabolism, pharmacokinetics, and drug disposition. The journal serves as an international forum for the publication of full-length/mini review, research articles and guest edited issues in drug metabolism. Current Drug Metabolism is an essential journal for academic, clinical, government and pharmaceutical scientists who wish to be kept informed and up-to-date with the most important developments. The journal covers the following general topic areas: pharmaceutics, pharmacokinetics, toxicology, and most importantly drug metabolism.
More specifically, in vitro and in vivo drug metabolism of phase I and phase II enzymes or metabolic pathways; drug-drug interactions and enzyme kinetics; pharmacokinetics, pharmacokinetic-pharmacodynamic modeling, and toxicokinetics; interspecies differences in metabolism or pharmacokinetics, species scaling and extrapolations; drug transporters; target organ toxicity and interindividual variability in drug exposure-response; extrahepatic metabolism; bioactivation, reactive metabolites, and developments for the identification of drug metabolites. Preclinical and clinical reviews describing the drug metabolism and pharmacokinetics of marketed drugs or drug classes.

Current Drug Targets aims to cover the latest and most outstanding developments on the medicinal chemistry and pharmacology of molecular drug targets e.g. disease specific proteins, receptors, enzymes, genes.

Cytotechnology incorporating Methods in Cell Science is an international journal covering up-to-date developments, methods and techniques in cell culture research involving in vitro systems, as well as the applications of that research in human and veterinary medicine, toxicology, animal and plant cell biotechnology. The aim is to centralize information on both the infrastructure of cell technology and the applied use of cell cultures and thus generate a better understanding of the many facets and disciplines needed to develop successful cell culture processes. Topics include the derivation, genetic modification and characterization of cell lines, cell culture techniques, cell culture systems, processes, reactors, scale-up, and industrial production, and the application of cells in a range of investigations, including application in gene therapy and tissue engineering. The journal publishes original papers, reviews, short communications, meeting reports and book reviews.

Dalton Transactions publishes high-quality original research, theoretical and computational studies that significantly advance the field of inorganic chemistry. Its scope includes organometallic, bioinorganic, medicinal inorganic, materials and nanomaterials, with applications including synthesis, catalysis, energy conversion/storage, electrical devices and medicine and sensors.

Diagnostics (ISSN 2075-4418) is an international scholarly open access journal on medical diagnostics. It publishes original research articles, reviews, communications and short notes on the research and development of medical diagnostics. There is no restriction on the length of the papers. Our aim is to encourage scientists to publish their experimental and theoretical research in as much detail as possible. Full experimental and/or methodological details must be provided for research articles.

The journal publishes original research findings (and reviews solicited by the Editor) on the subject of the identification of markers associated with the disease processes whether or not they are an integral part of the pathological lesion. The disease markers may be a genetic host factor predisposing to the disease or the occurrence of cell-surface markers, enzymes or other components, either in altered forms, abnormal concentrations or with abnormal tissue distribution. This journal is designed to provide a forum for publications dealing with original observations in this developing field on any aspect of the general topic including: * Identification of new genetic or non-genetic markers (e.g., cell-surface antigens, serum proteins, intra- and extra-cellular enzymes, cytogenic markers and DNA-sequences) * Population studies of new and existing markers, designed to elucidate information on their normal distribution as well as that in disease states * Amplification of knowledge about existing markers * Family studies of markers in disease * New techniques for identification and/or isolation of important marker molecules * Use of monoclonal antibodies for the definition of molecular structures associated with disease markers * Identification of disease-associated abnormalities in DNA using recombinant DNA techniques, gene-cloning and DNA restriction enzyme fragment polymorphisms * Identification of markers identifying malignantly transformed neoplastic cells.

Drug Metabolism Letters publishes letters, original research articles, mini-reviews, thematic issues based on mini-reviews and letters, commentaries, technical notes and drug clinical trial studies on major advances in all areas of drug metabolism and disposition.

ELECTROPHORESIS is an international journal that publishes original manuscripts on all aspects of electrophoresis. Topics include new or improved analytical and preparative methods, development of theory, and innovative applications of electrophoretic methods in the study of nucleic acids, proteins, and other compounds. Papers describing the application of standard electrophoretic methods will not be considered. Microfluidics and proteomics, which have been an integral part of the Journal since 2000 or earlier, have been added as subtitles in 2008 to make them more visible to the readers and authors (Papers in the areas of microfluidics and proteomics, which are not limited to electrophoresis-based methods will also be accepted for publication). As a natural expansion of the scope of the Journal, we now add Nanoanalysis as another subtitle. Nanoanalysis is a broad term, and therefore papers that will be accepted for publications in nanoanalysis must be focused on one or more of the following: (i) nanoscale electrokinetics and phenomena related to electric double layer and/or confinement in nano-sized geometry, (ii) single cell and sub- cellular analysis, (iii) nano-sensors and ultra-sensitive detection aspects (e.g., involving quantum dots, 'nano-electrodes' or nano-spray MS), (iv) nano-scale/nanopore DNA sequencing (next generation sequencing), (v) micro- and nano-scale sample preparation, (vi) nanoparticles and cells analyses by dielectrophoresis, (vii) separation-based analysis using nanoparticles, nanotubes and nanowires. Contributions will be allocated to one of the six subject categories: (i) general, (ii) nucleic acids, (iii) capillary electrophoresis and capillary electrochromatography (CE and CEC), (iv) microfluidics and miniaturization, (v) proteomics and two-dimensional electrophoresis (2-DE), and (vi) nanoanalysis. On submission authors are requested to indicate the preferred subject category. ELECTROPHORESIS will continue to serve as an indispensable vehicle for the dissemination of efficacious advances by covering all operative approaches from gels through capillaries to chips. Upcoming Special Issues:

Excellence in medical and scientific information.A leader in the field of medical publishing for the past 20 years, John Libbey Eurotext has compiled a prestigious catalogue of books and publishes more than 60 new titles every year. A wide variety of series: scientific meeting reports, monographs and practical guides both aimed at general practioners and specialists.

EJCI considers any original contribution from the most sophisticated basic molecular sciences to applied clinical and translational research and evidence-based medicine across a broad range of subspecialties. The EJCI publishes reports of high-quality research that pertain to the genetic, molecular, cellular, or physiological basis of human biology and disease, as well as research that addresses prevalence, diagnosis, course, treatment, and prevention of disease. We are primarily interested in studies directly pertinent to humans, but submission of robust in vitro and animal work is also encouraged. Interdisciplinary work and research using innovative methods and combinations of laboratory, clinical, and epidemiological methodologies and techniques is of great interest to the journal. Several categories of manuscripts (for detailed description see below) are considered: editorials, original articles (also including randomized clinical trials, systematic reviews and meta-analyses), reviews (narrative reviews), opinion articles (including debates, perspectives and commentaries); and letters to the Editor.

EXPERIMENTAL and MOLECULAR MEDICINE, EMM, publishes research papers and a limited number of reviews in the fields of basic and applied molecular biology, and experimental biochemistry in medicine. Research areas include analysis of gene structure, function and regulation; molecular mechanisms of genetic recombination; recombinant nucleic acid technology and gene therapy. EMM is also dedicated to the experimental biochemistry in medicine, including the regulatory mechanisms of body functions; structural biology and interaction between proteins and/or nucleic acids. Although special research areas are emphasized for publication, articles dealing with molecular biology and experimental biochemistry in other areas will also be welcomed.

Under new editorial leadership, Experimental and Molecular Pathology presents original articles on disease processes in relation to structural and biochemical alterations in mammalian tissues and fluids and on the application of newer techniques of molecular biology to problems of pathology in humans and other animals. The journal also publishes selected interpretive synthesis reviews by bench level investigators working at the "cutting edge" of contemporary research in pathology. In addition, special thematic issues present original research reports that unravel some of Nature's most jealously guarded secrets on the pathologic basis of disease.Research Areas include:• Stem cells• Neoangiogenesis• Molecular diagnostics• Polymerase chain reaction• In situ hybridization• DNA sequencing• Cell receptors• Carcinogenesis• Pathobiology of neoplasia• Complex infectious diseases• Transplantation• Cytokines• Flow cytomeric analysis• Inflammation• Cellular injury• Immunology and hypersensitivity• AthersclerosisBenefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services .Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com

Expert Opinion on Biological Therapy ranks #42 of 160 in the Biotechnology & Applied Microbiology category and #30 of 106 in the Medicine, Research & Experimental category in the 2009 ISI Journal Citation Reports.Expert Opinion on Biological Therapy (ISSN 1471-2598 [print], 1744-7682 [electronic]) is a MEDLINE-indexed, peer-reviewed, international journal publishing review articles and original papers on all aspects of biological therapy, providing expert opinion on the scope for future development.The Editors welcome: * Reviews covering gene therapy and gene transfer technologies; therapeutic peptides and proteins; vaccines and antibodies; cell- and tissue-based therapies * Drug Evaluations reviewing the clinical data on a particular biological agent * Original research papers reporting the results of clinical investigations on biological agents and biotherapeutic-based studies with a strong link to clinical practiceThe audience consists of scientists and managers in the healthcare and biopharmaceutical industry and others closely involved in the development of biological therapy for the treatment of human disease.

Expert Opinion on Therapeutic Targets ranks #53 of 249 in the Pharmacology & Pharmacy category in the 2010 ISI Journal Citation Reports.Expert Opinion on Therapeutic Targets (ISSN 1472-8222 [print], 1744-7631 [electronic]) is a MEDLINE-indexed, peer-reviewed, international journal publishing review articles and original papers on recently identified novel molecular drug targets, providing expert opinion on the scope for future development and impact on drug discovery.The Editors welcome: * Reviews covering novel disease targets at the molecular level and their implications on future drug development * Original research papers reporting results of target selection and validation studies and basic mechanism of action studies for investigative and marketed drugsThe audience consists of scientists, managers and decision makers in the pharmaceutical industry, and others closely involved in R&D.Read More: http://informahealthcare.com/page/Description?journalCode=ett.